This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centaurus Biopharma Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2017.
Company Filing History:
1 out of 33 
1 out of 121 Years Active: 2017
Title: The Innovative Contributions of Yongheng Wei
Introduction
Yongheng Wei, an accomplished inventor based in Beijing, China, has made significant contributions to the field of pharmaceuticals through his innovative research. With a focus on kinase modulating compounds, Wei's work aims to address various protein kinase-mediated diseases, showcasing his commitment to advancing medical science.
Latest Patents
Wei holds a patent for "Kinase modulating compounds, compositions containing the same and use thereof". This invention introduces a compound represented by a specific formula, designed to effectively modulate a kinase. The associated pharmaceutical composition and methodology provide new avenues for preventing or treating conditions linked to protein kinase activity.
Career Highlights
Throughout his career, Yongheng Wei has worked with notable companies, including Centaurus Biopharma Co., Ltd. and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His experiences in these organizations have allowed him to refine his skills and contribute to critical advancements in drug development.
Collaborations
Wei has collaborated with esteemed colleagues such as Dengming Xiao and Jijun Li. Their combined expertise has likely fostered a productive research environment, leading to breakthrough innovations in the pharmaceutical sector.
Conclusion
Yongheng Wei's dedication to innovation, particularly in the realm of kinase modulation, highlights the vital role inventors play in addressing pressing health challenges. His contributions not only exemplify individual creativity but also underscore the significance of collaboration in driving scientific progress.